These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 17082249

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population.
    Shi Y, Xiang P, Li L, Shen M.
    Forensic Sci Int; 2011 Apr 15; 207(1-3):183-7. PubMed ID: 21071160
    [Abstract] [Full Text] [Related]

  • 25. Correlation of CYP2B6-516G > T Polymorphism with Plasma Efavirenz Concentration and Depression in HIV-Infected Adults in Northern Thailand.
    Aurpibul L, Chotirosniramit N, Sugandhavesa P, Kosashunhanan N, Thetket S, Supindham T, Piyamongkol W, Supparatpinyo K.
    Curr HIV Res; 2012 Dec 15; 10(8):653-60. PubMed ID: 22950382
    [Abstract] [Full Text] [Related]

  • 26. Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study.
    Dobrinas M, Crettol S, Oneda B, Lahyani R, Rotger M, Choong E, Lubomirov R, Csajka C, Eap CB.
    Pharmacogenet Genomics; 2013 Feb 15; 23(2):84-93. PubMed ID: 23249875
    [Abstract] [Full Text] [Related]

  • 27. Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.
    Wyen C, Hendra H, Siccardi M, Platten M, Jaeger H, Harrer T, Esser S, Bogner JR, Brockmeyer NH, Bieniek B, Rockstroh J, Hoffmann C, Stoehr A, Michalik C, Dlugay V, Jetter A, Knechten H, Klinker H, Skaletz-Rorowski A, Fätkenheuer G, Egan D, Back DJ, Owen A, German Competence Network for HIV/AIDS Coordinators.
    J Antimicrob Chemother; 2011 Sep 15; 66(9):2092-8. PubMed ID: 21715435
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort.
    Carr DF, la Porte CJ, Pirmohamed M, Owen A, Cortes CP.
    J Antimicrob Chemother; 2010 Sep 15; 65(9):1889-93. PubMed ID: 20639527
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6.
    Mo SL, Liu YH, Duan W, Wei MQ, Kanwar JR, Zhou SF.
    Curr Drug Metab; 2009 Sep 15; 10(7):730-53. PubMed ID: 19702527
    [Abstract] [Full Text] [Related]

  • 32. Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women.
    Chantarangsu S, Cressey TR, Mahasirimongkol S, Capparelli E, Tawon Y, Ngo-Giang-Huong N, Jourdain G, Lallemant M, Chantratita W.
    J Antimicrob Chemother; 2009 Dec 15; 64(6):1265-73. PubMed ID: 19812066
    [Abstract] [Full Text] [Related]

  • 33. Plasma efavirenz concentrations and the association with CYP2B6-516G >T polymorphism in HIV-infected Thai children.
    Puthanakit T, Tanpaiboon P, Aurpibul L, Cressey TR, Sirisanthana V.
    Antivir Ther; 2009 Dec 15; 14(3):315-20. PubMed ID: 19474465
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients.
    Nakajima M, Komagata S, Fujiki Y, Kanada Y, Ebi H, Itoh K, Mukai H, Yokoi T, Minami H.
    Pharmacogenet Genomics; 2007 Jun 15; 17(6):431-45. PubMed ID: 17502835
    [Abstract] [Full Text] [Related]

  • 36. Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex.
    Zhang H, Sridar C, Kenaan C, Amunugama H, Ballou DP, Hollenberg PF.
    J Pharmacol Exp Ther; 2011 Sep 15; 338(3):803-9. PubMed ID: 21659470
    [Abstract] [Full Text] [Related]

  • 37. High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections.
    Sukasem C, Chamnanphon M, Koomdee N, Puangpetch A, Santon S, Jantararoungtong T, Prommas S, Chantratita W, Manosuthi W.
    Drug Metab Pharmacokinet; 2013 Sep 15; 28(5):391-7. PubMed ID: 23399569
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.